| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| May 9th, 2010 | 34 | Yes |
Popular Name: BMS-754807 BMS-754807
Find On: PubMed — Wikipedia — Google
CAS Numbers: 1001350-96-4 , [100135-09-9]
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 3.30 | 12.42 | -32.11 | 4 | 10 | 1 | 117 | 462.513 | 6 | ↓ |
| Mid Mid (pH 6-8) | 3.30 | 11.68 | -39.09 | 4 | 10 | 1 | 117 | 462.513 | 6 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| Target | IGF-1R | Selleck Chemicals |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| AKT1-2-E | RAC-alpha Serine/threonine-protein Kinase (cluster #2 Of 3), Eukaryotic | Eukaryotes | 22 | 0.32 | Binding ≤ 10μM |
| CCNE1-1-E | G1/S-specific Cyclin E1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1035 | 0.25 | Binding ≤ 10μM |
| CCNE2-1-E | G1/S-specific Cyclin E2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1035 | 0.25 | Binding ≤ 10μM |
| CDK2-1-E | Cyclin-dependent Kinase 2 (cluster #1 Of 5), Eukaryotic | Eukaryotes | 1035 | 0.25 | Binding ≤ 10μM |
| IGF1R-1-E | Insulin-like Growth Factor 1 Receptor (cluster #1 Of 2), Eukaryotic | Eukaryotes | 13 | 0.32 | Binding ≤ 10μM |
| CP3A4-2-E | Cytochrome P450 3A4 (cluster #2 Of 4), Eukaryotic | Eukaryotes | 7000 | 0.21 | ADME/T ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| IGF1R_MOUSE | Q60751 | Insulin-like Growth Factor 1 Receptor, Mouse | 13 | 0.32 | Binding ≤ 1μM |
| IGF1R_HUMAN | P08069 | Insulin-like Growth Factor I Receptor, Human | 2 | 0.36 | Binding ≤ 1μM |
| AKT1_MOUSE | P31750 | RAC-alpha Serine/threonine-protein Kinase, Mouse | 22 | 0.32 | Binding ≤ 1μM |
| CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 1035 | 0.25 | Binding ≤ 10μM |
| CCNE1_HUMAN | P24864 | G1/S-specific Cyclin E1, Human | 1035 | 0.25 | Binding ≤ 10μM |
| CCNE2_HUMAN | O96020 | G1/S-specific Cyclin E2, Human | 1035 | 0.25 | Binding ≤ 10μM |
| IGF1R_MOUSE | Q60751 | Insulin-like Growth Factor 1 Receptor, Mouse | 13 | 0.32 | Binding ≤ 10μM |
| IGF1R_HUMAN | P08069 | Insulin-like Growth Factor I Receptor, Human | 2 | 0.36 | Binding ≤ 10μM |
| AKT1_MOUSE | P31750 | RAC-alpha Serine/threonine-protein Kinase, Mouse | 22 | 0.32 | Binding ≤ 10μM |
| CP3A4_HUMAN | P08684 | Cytochrome P450 3A4, Human | 7000 | 0.21 | ADME/T ≤ 10μM |
| Description | Species |
|---|---|
| Activation of ATR in response to replication stress | |
| Activation of BAD and translocation to mitochondria | |
| Activation of the pre-replicative complex | |
| Aflatoxin activation and detoxification | |
| AKT phosphorylates targets in the cytosol | |
| AKT phosphorylates targets in the nucleus | |
| AKT-mediated inactivation of FOXO1A | |
| Butyrate Response Factor 1 (BRF1) destabilizes mRNA | |
| CD28 dependent PI3K/Akt signaling | |
| CDK-mediated phosphorylation and removal of Cdc6 | |
| Constitutive PI3K/AKT Signaling in Cancer | |
| CTLA4 inhibitory signaling | |
| Cyclin A/B1 associated events during G2/M transition | |
| Cyclin A:Cdk2-associated events at S phase entry | |
| Cyclin E associated events during G1/S transition | |
| deactivation of the beta-catenin transactivating complex | |
| DNA Damage/Telomere Stress Induced Senescence | |
| Downregulation of ERBB2:ERBB3 signaling | |
| E2F mediated regulation of DNA replication | |
| eNOS activation | |
| Factors involved in megakaryocyte development and platelet production | |
| G beta:gamma signalling through PI3Kgamma | |
| G0 and Early G1 | |
| G1/S-Specific Transcription | |
| G2 Phase | |
| GPVI-mediated activation cascade | |
| Integrin alphaIIb beta3 signaling | |
| IRS-related events triggered by IGF1R | |
| KSRP destabilizes mRNA | |
| Meiotic recombination | |
| Negative regulation of the PI3K/AKT network | |
| Orc1 removal from chromatin | |
| p53-Dependent G1 DNA Damage Response | |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 | |
| PIP3 activates AKT signaling | |
| Regulation of APC/C activators between G1/S and early anaphase | |
| SCF(Skp2)-mediated degradation of p27/p21 | |
| Senescence-Associated Secretory Phenotype (SASP) | |
| SHC-related events triggered by IGF1R | |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | |
| Translocation of GLUT4 to the plasma membrane | |
| VEGFR2 mediated vascular permeability | |
| Xenobiotics |
No pre-computed analogs available. Try a structural similarity search.